Job Description

The Senior Medical Director, Global Medical Lead, Early Oncology Pipeline (GML-EOP) serves as the internal and external medical expert for the Pfizer Oncology early development portfolio, working closely with and giving medical input to BU leadership, asset team leads, clinical leads, PHI leads, publications leads, and other relevant internal functions, as well as serving as expert and point of contact for external stakeholders including phase I investigators, key opinion leaders, research organizations, and other collaborators such as 3rd party companies. The GML-EOP reports to the VP, Global Medical Lead, Prostate, Biosimilars and EOP Franchise.

ROLE RESPONSIBILITIES

The GML-EOP provides medical expertise to various internal functions, as well as external physicians and researchers and is responsible for leading medical deliverables including insight gathering, therapeutic landscape and disease assessments, publications, and advisory boards. The GML-EOP is responsible for building and maintaining strong external-facing interactions with medical experts and other stakeholders globally to inform early clinical development and life cycle plans.

The GML-EOP is a key contributor to the development of life cycle programs, commercial and clinical development strategy. To this end, he/she works with the various cross-functional and franchise teams. The GML-EOP acts as an interface between the early development teams and the medical affairs franchise teams, chairs the Global Review Committee for Investigator Sponsored Research (ISR), and leads the evaluation of external study proposals. In collaboration with the Publications Lead, the GML-EOP leads planning and execution of publications out of the early development program. Overlooking the entire early development program, the GML-EOP develops training materials and provides medical education. In the interaction with investigators and treating physicians, the GML-EOP will discuss the individual experience with compounds in the first-in-human studies with a focus on the adverse event profile and its management. The GML-EOP will review relevant literature, and attend congresses, and will develop medical and scientific assessments of current developments. He/she will discuss and review new data with leading global scientists and clinical investigators, and derive global development strategies for the early development portfolio.

Qualifications:

* 10 plus years experience in the pharmaceutical industry, experience in Medical Affairs strongly preferred

* Holds both an MD and a PhD degree with extensive oncology basic science, clinical and medical knowledge

* Strong leadership, oral and written communication skills

* Understanding of principles of pharmacovigilance and risk/benefit analysis

* Ability to lead matrixed, cross-functional work teams

* Global mindset and experience in multiple markets, proven ability to partner cross culturally/regionally

* In-depth understanding and experience with study methodology, protocol design, safety evaluation, and data analysis

* Fluency in written and spoken English required

* Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Other Job Details:

Last Date to Apply for Job: April 16, 2021

Additional Location Information: La Jolla, CA is strongly preferred.

Open to candidates based in other US locations

Eligible for Relocation Package

Eligible for Employee Referral Bonus

LI-PFE

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Medical

LI-PFE